Format

Send to

Choose Destination
Sci Rep. 2016 Feb 11;6:20681. doi: 10.1038/srep20681.

Metabolic disruption identified in the Huntington's disease transgenic sheep model.

Author information

1
Centre for Brain Research, University of Auckland, Auckland, 1010, New Zealand.
2
Molecular Biology and Reproductive Technology Laboratories, South Australian Research and Development, Adelaide, SA 5350, Australia.
3
Research &Development, Livestock Improvement Corporation, Hamilton, 3240, New Zealand.
4
Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston MA 02114, United States of America.

Abstract

Huntington's disease (HD) is a dominantly inherited, progressive neurodegenerative disorder caused by a CAG repeat expansion within exon 1 of HTT, encoding huntingtin. There are no therapies that can delay the progression of this devastating disease. One feature of HD that may play a critical role in its pathogenesis is metabolic disruption. Consequently, we undertook a comparative study of metabolites in our transgenic sheep model of HD (OVT73). This model does not display overt symptoms of HD but has circadian rhythm alterations and molecular changes characteristic of the early phase disease. Quantitative metabolite profiles were generated from the motor cortex, hippocampus, cerebellum and liver tissue of 5 year old transgenic sheep and matched controls by gas chromatography-mass spectrometry. Differentially abundant metabolites were evident in the cerebellum and liver. There was striking tissue-specificity, with predominantly amino acids affected in the transgenic cerebellum and fatty acids in the transgenic liver, which together may indicate a hyper-metabolic state. Furthermore, there were more strong pair-wise correlations of metabolite abundance in transgenic than in wild-type cerebellum and liver, suggesting altered metabolic constraints. Together these differences indicate a metabolic disruption in the sheep model of HD and could provide insight into the presymptomatic human disease.

PMID:
26864449
PMCID:
PMC4749952
DOI:
10.1038/srep20681
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center